Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from the Morgridge Institute for Research and Northwestern University have created an efficient way to target and repair defective genes.
Writing today (Monday, Aug. 12, 2013) in the Proceedings of the National Academy of Sciences, the team reports that the novel technique is much simpler than previous methods and establishes the groundwork for major advances in regenerative medicine, drug screening and biomedical research.
Zhonggang Hou of the Morgridge Institute’s regenerative biology team and Yan Zhang of Northwestern University served as first authors on the study; James Thomson, director of regenerative biology at the Morgridge Institute, and Erik Sontheimer, professor of molecular biosciences at Northwestern University, served as principal investigators.
“With this system, there is the potential to repair any genetic defect, including those responsible for some forms of breast cancer, Parkinson’s and other diseases,” Hou said. “The fact that it can be applied to human pluripotent stem cells opens the door for meaningful therapeutic applications.”
Zhang said the Northwestern University team focused on Neisseria meningitidis bacteria because it is a good source of the Cas9 protein needed for precisely cleaving damaged sections of DNA.
“We are able to guide this protein with different types of small RNA molecules, allowing us to carefully remove, replace or correct problem genes,” Zhang said. “This represents a step forward from other recent technologies built upon proteins such as zinc finger nucleases and TALENs.”
These previous gene correction methods required engineered proteins to help with the cutting. Hou said scientists can synthesize RNA for the new process in as little as one to three days – compared with the weeks or months needed to engineer suitable proteins.
The Latest on: Regenerative medicine
- Podcast: Spotlight on Science: Regenerative Medicine and the Knight Campus on October 4, 2018 at 6:00 am
Many animals possess the ability to regenerate entire limbs, but our human bodies have limited regenerative properties. We can heal our broken bones, and we could regenerate the tip of our finger if c... […]
- ACell Announces New Research Investigating its Hernia Devices in Regenerative Medicine on October 4, 2018 at 4:42 am
COLUMBIA, Md., Oct. 4, 2018 /PRNewswire/ -- ACell, Inc. today announced the publication ahead of print of the article entitled "Comparison of in vivo remodeling of urinary bladder matrix and acellular ... […]
- BlueRock Therapeutics President and CEO Emile Nuwaysir elected to serve as Vice Chairman of the Alliance for Regenerative Medicine on October 3, 2018 at 6:00 am
CAMBRIDGE, Mass., Oct. 3, 2018 /PRNewswire/ -- BlueRock Therapeutics, LP, an engineered cell therapy company focused on leveraging its novel Cell+Gene platform to develop regenerative medicines for in... […]
- The Alliance for Regenerative Medicine Announces Election of 2019 ARM Officers, Executive Committee, and Board of Directors on October 3, 2018 at 6:00 am
WASHINGTON, D.C., Oct. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and ... […]
- An interview with the Chair for TERMIS-Europe, Prof Heinz Redl on October 3, 2018 at 1:25 am
BMC Biomedical Engineering recently attended the 2018 TERMIS World Congress, where we had the privilege to meet Prof Heinz Redl, the Chair for TERMIS-Europe and a renowned thought leader in the field ... […]
- Stem Cells @ 20: The Stem Cell and Regenerative Medicine center galvanizes stem cell research on October 2, 2018 at 6:12 am
Since University of Wisconsin–Madison researcher James Thomson and colleagues derived the first human embryonic stem cells 20 years ago, research universities and biotechnology companies around the gl... […]
- Regenerative Medicine Market Review with 2018-2025 Forecasts Research Report on October 1, 2018 at 5:06 am
The latest niche market study “Global Regenerative Medicine Market Drivers, Restraints, Potential Growth Opportunities, Product Size, Application Estimation, Vendor Competitive Landscape, Trends and F... […]
- 2nd Annual Summit on Cell Therapy and Regenerative Medicine on October 1, 2018 at 4:50 am
Â· Eminent Scientists/Research Professors in the field of cell therapy and regenerative medicine Â· Clinicians Â· Junior/Senior research fellows Â· Directors of Biopharma companies Â· Members of diffe... […]
- Regenerative Medicine Market Forecast 2017 - 2025 : Vericel Corporation, Japan Tissue Engineering Co., Ltd., Stryker Corporation on October 1, 2018 at 3:50 am
Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs, and ... […]
- Regenerative Medicine Market Research Report by Key Players Analysis 2025 on September 27, 2018 at 1:46 pm
Regenerative medicine is an interdisciplinary field of medicine that is used for developing methods to grow, repair or replace diseased or damaged cells, tissues, and organs. Regenerative medicine inv... […]
via Google News and Bing News